Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q)

MLA

Pierre Fenaux, et al. “Clinical Characteristics and Outcomes According to Age in Lenalidomide-Treated Patients with RBC Transfusion-Dependent Lower-Risk MDS and Del(5q).” Journal of Hematology & Oncology, vol. 10, no. 1, June 2017, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13045-017-0491-2.

APA

Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Moshe Mittelman, Petra Muus, Stephen D. Nimer, Eva Hellström-Lindberg, Bayard L. Powell, Agnes Guerci-Bresler, Mikkael A. Sekeres, H. Joachim Deeg, Consuelo del Cañizo, Peter L. Greenberg, Jamile M. Shammo, Barry Skikne, Xujie Yu, & Alan F. List. (2017). Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q). Journal of Hematology & Oncology, 10(1), 1–8. https://doi.org/10.1186/s13045-017-0491-2

Chicago

Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Moshe Mittelman, Petra Muus, Stephen D. Nimer, et al. 2017. “Clinical Characteristics and Outcomes According to Age in Lenalidomide-Treated Patients with RBC Transfusion-Dependent Lower-Risk MDS and Del(5q).” Journal of Hematology & Oncology 10 (1): 1–8. doi:10.1186/s13045-017-0491-2.